TTrialPathMatch Me to Trials
← Back to trials
RecruitingClear Cell Renal Cell CarcinomaRenal Cell Carcinoma (RCC)Stage II Renal Pelvis Cancer AJCC v8

Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer

Eligible age

18+ yrs

Accepts

All genders

Locations

42 states

Healthy volunteers

No

See if you qualify for this study

Answer a few quick questions about your location and health. Takes about a minute.

Check my eligibility →

About this study

This phase III trial compares the effect of adding tivozanib to standard therapy pembrolizumab versus pembrolizumab alone for the treatment of patients with high-risk renal cell carcinoma (RCC). Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Tivozanib is in a class of medications called kinase inhibitors. It works by blocking the action of the abnormal protein that signals tumor cells to multiply. This helps stop the spread of tumor cells. Giving pembrolizumab and tivozanib together may work better than pembrolizumab alone in treating patients with RCC.

Sponsor: Alliance for Clinical Trials in Oncology

You may qualify if…

  • ✓ • Histologically confirmed diagnosis of RCC with clear cell component with or without sarcomatoid features following complete resection of the primary tumor (radical or partial nephrectomy)
  • ✓ Note: Patients with microscopically positive soft tissue or vascular margins without gross residual disease are permitted
  • ✓ Intermediate-high risk RCC:
  • ✓ pT2 grade 4 or sarcomatoid features, N0M0
  • ✓ pT3 any grade N0, M0
  • ✓ High-risk RCC
  • ✓ pT4, any grade, N0, M0
  • ✓ pT, any stage., any grade, N+, M0

Where it's recruiting

Arizona

Phoenix · Tucson

Arkansas

Jonesboro · Little Rock

California

Auburn · Beverly Hills · Duarte · Irvine …

Colorado

Aurora · Colorado Springs · Denver · Fort Collins …

Connecticut

Avon · Bridgeport · Derby · Fairfield …

Delaware

Millville · Newark · Rehoboth Beach

District of Columbia

Washington D.C.

Florida

Gainesville · Miami

Georgia

Atlanta · Johns Creek

Idaho

Boise · Coeur d'Alene · Fruitland · Meridian …

Illinois

Aurora · Barrington · Bloomington · Canton …

Indiana

Avon · Carmel · Indianapolis

Source: ClinicalTrials.gov · NCT06661720 · last updated 2026-11-03